Profilo
Mariana Nacht worked as Vice President & Head-Biology at Padlock Therapeutics, Inc. from 2014 to 2016.
She then worked as Vice President-Cancer Biology at Kdac Therapeutics, Inc. from 2017 to 2018.
In 2018, she became the Chief Scientific Officer at Vivid Biosciences LLC until 2019.
From 2019 to 2020, she worked as the Chief Scientific Officer at Cereius, Inc. In 2020, she became the Chief Scientific Officer at LogicBio Therapeutics, Inc. Dr. Nacht holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Tufts University.
Precedenti posizioni note di Mariana Nacht
| Società | Posizione | Fine |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 16/11/2022 |
Cereius, Inc.
Cereius, Inc. BiotechnologyHealth Technology Develops novel radio-labeled therapeutics for treating solid tumor brain metastasis | Direttore Tecnico/Scientifico/R&S | 01/11/2020 |
Vivid Biosciences LLC | Direttore Tecnico/Scientifico/R&S | 01/07/2019 |
Kdac Therapeutics, Inc.
Kdac Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops novel treatments for cancer patients | Corporate Officer/Principal | 01/01/2018 |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Develops medicines targeting protein-arginine deiminases | Corporate Officer/Principal | 01/07/2016 |
Formazione di Mariana Nacht
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University
Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Develops medicines targeting protein-arginine deiminases | Health Technology |
LogicBio Therapeutics, Inc.
LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines and therapies for bone metabolism, cardiology, neurology and rare diseases | Health Technology |
Cereius, Inc.
Cereius, Inc. BiotechnologyHealth Technology Develops novel radio-labeled therapeutics for treating solid tumor brain metastasis | Health Technology |
Kdac Therapeutics, Inc.
Kdac Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops novel treatments for cancer patients | Health Technology |
Vivid Biosciences LLC |
















